2019
DOI: 10.1590/s2175-97902019000117032
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of new 2-{2,3-dihydro-1,4-benzodioxin-6-yl[(4-methylphenyl) sulfonyl]amino}-N-(un/substituted-phenyl)acetamides as α-glucosidase and acetylcholinesterase inhibitors and their in silico study

Abstract: The aim of the present research work was to investigate the enzyme inhibitory potential of some new sulfonamides having benzodioxane and acetamide moieties. The synthesis was started by the reaction of N-2,3-dihydrobenzo[1,4]-dioxin-6-amine (1) with 4-methylbenzenesulfonyl chloride (2) in the presence of 10% aqueous Na 2 CO 3 to yield N-(2,3-dihydrobenzo[1,4]-dioxin-6-yl)-4-methylbenzenesulfonamide (3), which was then reacted with 2-bromo-N-(un/substituted-phenyl)acetamides (6a-l) in DMF and lithium hydride as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Similarly, these derivatives were proven more effective α-glucosidase inhibitors in comparison to the reported benzimidazoles [70], dihydropyrano[2,3-c]pyrazoles [71] and 2-thioxobenzo[g]quinazolines [72] but less potent than the sulfonamide chalcones [44]. Similarly, compounds 12i and 12k, the most potent derivatives of the series, having IC 50 values of 25.88 and 30.45 µM, respectively, were also found better α-glucosidase inhibitors compared to the recently reported N-arylacetamides [73]. These derivatives were found about 2.7-and 1.7-fold more potent enzyme inhibitors compared to the acarbose.…”
Section: α-Glucosidase Inhibitionmentioning
confidence: 65%
“…Similarly, these derivatives were proven more effective α-glucosidase inhibitors in comparison to the reported benzimidazoles [70], dihydropyrano[2,3-c]pyrazoles [71] and 2-thioxobenzo[g]quinazolines [72] but less potent than the sulfonamide chalcones [44]. Similarly, compounds 12i and 12k, the most potent derivatives of the series, having IC 50 values of 25.88 and 30.45 µM, respectively, were also found better α-glucosidase inhibitors compared to the recently reported N-arylacetamides [73]. These derivatives were found about 2.7-and 1.7-fold more potent enzyme inhibitors compared to the acarbose.…”
Section: α-Glucosidase Inhibitionmentioning
confidence: 65%